ACRO BIOMEDICAL CO., LTD. Operating Lease Right-of-Use Assets
ACRO BIOMEDICAL CO., LTD. (ACBM) had Operating Lease Right-of-Use Assets of $0 as of 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Balance Sheet › Assets
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-02-11
- 2025-12-31: Operating Lease, Right-of-Use Asset $0.00.
- 2025-09-30: Operating Lease, Right-of-Use Asset $0.00.
- 2025-06-30: Operating Lease, Right-of-Use Asset $13.65K.
- 2025-03-31: Operating Lease, Right-of-Use Asset $20.32K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-11 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-10 |
| 2025-06-30 | $13.65K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $20.32K 10-Q · filed 2025-07-24 |
| 2024-12-31 | $26.90K 10-K · filed 2026-02-11 |
| 2024-09-30 | $33.38K 10-Q · filed 2025-07-23 |
| 2024-06-30 | $39.76K 10-Q · filed 2025-07-23 |
| 2024-03-31 | $46.04K 10-Q · filed 2025-07-22 |
| 2023-12-31 | $52.23K 10-K · filed 2025-07-24 |
| 2023-09-30 | $6.53K 10-Q · filed 2025-07-11 |
| 2023-06-30 | $12.99K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $19.39K 10-Q · filed 2023-08-02 |
| 2022-12-31 | $25.72K 10-K · filed 2025-07-18 |
| 2022-09-30 | $31.99K 10-Q · filed 2022-11-21 |
| 2022-06-30 | $38.20K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $44.35K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $50.43K 10-K · filed 2023-07-21 |
| 2021-09-30 | $6.27K 10-Q · filed 2021-11-22 |
| 2021-06-30 | $12.47K 10-Q · filed 2021-08-23 |
| 2021-03-31 | $18.62K 10-Q · filed 2021-05-24 |
| 2020-12-31 | $24.70K 10-K · filed 2022-04-15 |
| 2020-12-30 | $24.70K 10-Q · filed 2021-11-22 |
| 2020-09-30 | $30.72K 10-Q · filed 2020-11-17 |
| 2020-06-30 | $36.68K 10-Q · filed 2020-08-19 |
| 2020-03-31 | $42.58K 10-Q · filed 2020-05-19 |
| 2019-12-31 | $48.42K 10-K · filed 2021-04-02 |